Stay updated with breaking news from Zyme Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nobel prize winning CRISPR technology to be applied in development of genetically engineered cell and animal models ERS Genomics Limited, which was formed to provide broad access to the foundational
Royalty bearing license agreement to develop and commercialise an Affimer-based in-vitro diagnostic test Avacta Group plc (AIM: AVCT), the developer of innovative cancer therapies and diagnostics
License to Nobel prize winning CRISPR technology supports internal research and development ERS Genomics Limited, which was formed to provide broad access to foundational CRISPR/Cas9 intellectual
Investegate announcements from Avacta Group PLC, Electronic Communications with Shareholders
ERS Genomics Expands Team With Appointment of Jon Kratochvil as VP Business Development Jon Kratochvil joins as Vice President for Business Development Licensing for North America ERS Genomics Limited ("ERS"), which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, today announced the appointment of Jon Kratochvil as Vice-President for Business Development Licensing for North America. With over 30 years of experience, Jon becomes a core member of ERS' global team. Jon joins ERS from MilliporeSigma where he was Dire...